Quick Answer
Ascendis Pharma A/S reported Gross Profit of $625.22 million for fiscal year 2025.
Ascendis Pharma A/S Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $625.22M | +95.8% |
| 2024 | $319.38M | +43.7% |
| 2023 | $222.32M | +469.5% |
| 2022 | $39.04M | +817.4% |
| 2021 | $4.25M | -38.8% |
| 2020 | $6.95M | -48.0% |
| 2019 | $13.38M | — |
- Ascendis Pharma A/S showed an increase of +95.8% in Gross Profit compared to the prior fiscal year.
- Over the 2019–2025 period, Ascendis Pharma A/S’s gross profit has grown by 4574.5% (from $13.38 million to $625.22 million).
- The most recent figure is from Ascendis Pharma A/S’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: